Location: Home
  • search
  • go
  • Relate News
  • 2/6/2018Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China
  • 2/6/2018CFDA Vice Minister SUN Xianze to Leave the Agency
  • 2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership
  • 2/6/2018BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for I...
  • 2/6/2018China to Step Up Surveillance of Online Drug Sales
  • 2/6/2018South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...
  • 2/5/2018Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...
  • 2/5/2018Heads of CFDA and the Bitish Medicines and Healthcare Products Regulat...
  • 2/5/2018More Provincial Governments Liberalize Non-essential Drug Use in Prima...
  • 2/2/2018Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...
  • 2/2/2018Fosun-backed Shanghai Henlius Biotech Plans IPO in Hong Kong
  • 2/2/2018AstraZeneca Counts on China and Anticancer Sales for Renewed Growth
  • 2/2/2018This Is Why Chinese Companies Are Suddenly Targeting Australian Health...
  • 2/2/2018Puma Biotech and CANbridge Enter Exclusive Licensing for NERLYNX (nera...
  • 2/2/2018Roche CEO Considers China Business "A Large Focus"
  • 2/2/2018Shanghai Pharma Completes Acquisition of Cardinal Health's China Busin...
  • 2/2/2018Recent Executive Moves
  • 2/2/2018Four Central Government Agencies Issue Joint Notice for Centralized Pr...
  • 2/1/2018Lundbeck Launches PD Drug Azilect in China
  • 1/31/2018BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...
  • 1/31/2018CJ Healthcare Licenses EPO Biosimilar to NCPC GeneTech
  • 1/31/2018Financial-related Company News in Brief
  • 1/31/2018Light at the End of Tunnel in the Supposedly Hopeful Year of the "...
  • 1/31/2018Novartis Launches Asthma Drug Xolair (omalizumab) in China
  • 1/31/2018Lee's Subsidiary Granted Clinical Trial Approval in Three Separate Can...
  • 1/30/2018Why Most Small Players May Not Survive China's Pharmaceutical Industry...
  • 1/30/2018WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing C...
  • 1/30/2018TLC, Jixi Biotech to Set Up a JV for the Chinese Market
  • 1/30/2018CASI Pharma Acquires ANDA Portfolio From Sandoz
  • 1/30/2018CFDA Lays Out Eight Major Food and Drug Regulatory Tasks in 2018
  • Page:349/789 Total number of articles:23668: [First][<<] [347] [348] [349] [350] [351] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group